$TMHC
Taylor Morrison Home Corp Stock $tmhc

$tmhc Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000162828024032842 Filed on July 24, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$2.121B	$1.991B
YoY Change	26.58%	-3.37%
Cost Of Revenue	$1.590B	$1.519B
YoY Change	23.83%	-2.7%
Gross Profit	$531.1M	$472.3M
YoY Change	35.57%	-5.48%
Gross Profit Margin	25.04%	23.72%
Selling, General & Admin	$199.3M	$196.7M
YoY Change	18.8%	7.11%
% of Gross Profit	37.54%	41.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.913M	$11.33M
YoY Change	7.75%	53.31%
% of Gross Profit	1.87%	2.4%
Operating Expenses	$199.3M	$196.7M
YoY Change	18.8%	2.34%
Operating Profit	$331.7M	$275.6M
YoY Change	48.14%	-10.38%
Interest Expense	-$3.379M	-$4.087M
YoY Change	-143.88%	-149.21%
% of Operating Profit	-1.02%	-1.48%
Other Income/Expense, Net	$256.0K	-$10.96M
YoY Change	-90.9%	219.74%
Pretax Income	$332.7M	$267.2M
YoY Change	45.66%	-15.37%
Income Tax	$81.22M	$67.30M
% Of Pretax Income	24.41%	25.19%
Net Earnings	$251.1M	$199.5M
YoY Change	47.12%	-14.98%
Net Earnings / Revenue	11.84%	10.02%
Basic Earnings Per Share	$2.41	$1.89
Diluted Earnings Per Share	$2.37	$1.86
COMMON SHARES
Basic Shares Outstanding	104.2M shares	105.8M shares
Diluted Shares Outstanding	106.1M shares	107.2M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$256.4M	$246.8M
YoY Change	-58.22%	-79.89%
Cash & Equivalents	$256.4M	$246.8M
Short-Term Investments
Other Short-Term Assets	$336.1M	$330.1M
YoY Change	9.96%	26.44%
Inventory	$4.393B	$4.313B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$7.241B	$7.078B
YoY Change	9.9%	2.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$322.5M	$316.7M
YoY Change	22.77%	4.03%
Goodwill	$663.2M	$663.2M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$671.0M	$586.1M
YoY Change	25.22%	13.98%
Other Assets	$334.0M	$382.8M
YoY Change	7.68%	7.7%
Total Long-Term Assets	$2.060B	$2.021B
YoY Change	11.44%	9.99%
TOTAL ASSETS
Total Short-Term Assets	$7.241B	$7.078B
Total Long-Term Assets	$2.060B	$2.021B
Total Assets	$9.300B	$9.099B
YoY Change	10.23%	4.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$269.3M	$310.7M
YoY Change	-1.28%	10.35%
Accrued Expenses	$614.3M	$600.6M
YoY Change	15.95%	20.02%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.197B	$1.260B
YoY Change	1.15%	8.12%
LONG-TERM LIABILITIES
Long-Term Debt	$2.143B	$2.150B
YoY Change	7.59%	-10.18%
Other Long-Term Liabilities	$237.1M	$162.1M
YoY Change	174.1%	72.17%
Total Long-Term Liabilities	$2.380B	$2.312B
YoY Change	14.52%	-7.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.197B	$1.260B
Total Long-Term Liabilities	$2.380B	$2.312B
Total Liabilities	$3.577B	$3.573B
YoY Change	9.66%	-2.67%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.705B	$5.527B
YoY Change
Total Liabilities & Shareholders Equity	$9.300B	$9.099B
YoY Change	10.23%	4.0%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$251.1M	$199.5M
YoY Change	47.12%	-14.98%
Depreciation, Depletion And Amortization	$9.913M	$11.33M
YoY Change	7.75%	53.31%
Cash From Operating Activities	$135.9M	-$233.3M
YoY Change	-340.51%	-189.86%
INVESTING ACTIVITIES
Capital Expenditures	$8.829M	$8.330M
YoY Change	-66.04%	15.09%
Acquisitions
YoY Change
Other Investing Activities	-$16.18M	-$15.93M
YoY Change	-30.55%	22.44%
Cash From Investing Activities	-$25.01M	-$24.26M
YoY Change	-49.27%	19.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-102.4M	-51.04M
YoY Change	-79.83%	-148.99%
NET CHANGE
Cash From Operating Activities	135.9M	-233.3M
Cash From Investing Activities	-25.01M	-24.26M
Cash From Financing Activities	-102.4M	-51.04M
Net Change In Cash	8.520M	-308.6M
YoY Change	-101.39%	-189.82%
FREE CASH FLOW
Cash From Operating Activities	$135.9M	-$233.3M
Capital Expenditures	$8.829M	$8.330M
Free Cash Flow	$127.1M	-$241.7M
YoY Change	-254.01%	-195.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	349066000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	326087000	usd
CY2024Q2	tmhc	Estimated Development Liability EstimatedDevelopmentLiability	27416000	usd
CY2023Q4	tmhc	Estimated Development Liability EstimatedDevelopmentLiability	27440000	usd
CY2024Q2	us-gaap	Senior Notes SeniorNotes	1469574000	usd
CY2023Q4	us-gaap	Senior Notes SeniorNotes	1468695000	usd
CY2024Q2	us-gaap	Loans Payable LoansPayable	404242000	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	394943000	usd
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2024Q2	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	276205000	usd
CY2023Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	153464000	usd
CY2024Q2	tmhc	Liabilities Attributable To Consolidated Option Agreements LiabilitiesAttributableToConsolidatedOptionAgreements	134700000	usd
CY2023Q4	tmhc	Liabilities Attributable To Consolidated Option Agreements LiabilitiesAttributableToConsolidatedOptionAgreements	71618000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	3572527000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3339801000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5526542000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5332286000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9099069000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8672087000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1991053000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2060564000	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	1518765000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1560879000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	472288000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	499685000	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	113956000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	113034000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	82779000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70649000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2628000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3186000	usd
CY2024Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-4087000	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5120000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6877000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8549000	usd
CY2024Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	267217000	usd
CY2023Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	315759000	usd
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	516097000	usd
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	564178000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	67303000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	80854000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	125022000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	138045000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	199914000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	234905000	usd
	us-gaap	Profit Loss ProfitLoss	391075000	usd
	us-gaap	Profit Loss ProfitLoss	426133000	usd
CY2024Q2	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Redeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersRedeemable	454000	usd
CY2023Q2	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Redeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersRedeemable	303000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Redeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersRedeemable	1345000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Redeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersRedeemable	480000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	199460000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	234602000	usd
	us-gaap	Net Income Loss NetIncomeLoss	389730000	usd
	us-gaap	Net Income Loss NetIncomeLoss	425653000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.89
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.91
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.86
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.85
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105500000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109210000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105979000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108822000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107249000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110856000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107961000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110466000	shares
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5426168000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	199914000	usd
CY2024Q2	tmhc	Stock Issued Value Exercise Of Stock Options And Issuance Of Restricted Stock Units Net StockIssuedValueExerciseOfStockOptionsAndIssuanceOfRestrictedStockUnitsNet	1425000	usd
CY2024Q2	tmhc	Treasury Stock Value Acquired Including Excise Tax Cost Method TreasuryStockValueAcquiredIncludingExciseTaxCostMethod	106870000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	6072000	usd
CY2024Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	167000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5526542000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1500000	usd
CY2024Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4846546000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	234905000	usd
CY2023Q2	tmhc	Stock Issued Value Exercise Of Stock Options And Issuance Of Restricted Stock Units Net StockIssuedValueExerciseOfStockOptionsAndIssuanceOfRestrictedStockUnitsNet	8591000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	5271000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5095313000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8900000	usd
	us-gaap	Profit Loss ProfitLoss	391075000	usd
	tmhc	Stock Issued Value Exercise Of Stock Options And Issuance Of Restricted Stock Units Net StockIssuedValueExerciseOfStockOptionsAndIssuanceOfRestrictedStockUnitsNet	-9431000	usd
	tmhc	Treasury Stock Value Acquired Including Excise Tax Cost Method TreasuryStockValueAcquiredIncludingExciseTaxCostMethod	198519000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	11555000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	424000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5526542000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5500000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	100000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4646859000	usd
	us-gaap	Profit Loss ProfitLoss	426133000	usd
	tmhc	Stock Issued Value Exercise Of Stock Options And Issuance Of Restricted Stock Units Net StockIssuedValueExerciseOfStockOptionsAndIssuanceOfRestrictedStockUnitsNet	13084000	usd
	tmhc	Treasury Stock Value Acquired Including Excise Tax Cost Method TreasuryStockValueAcquiredIncludingExciseTaxCostMethod	3568000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	12804000	usd
	tmhc	Noncontrolling Interest Increase Decrease From Contributions Distributions To Noncontrolling Interest Holders NoncontrollingInterestIncreaseDecreaseFromContributionsDistributionsToNoncontrollingInterestHolders	1000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5095313000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	22400000	usd
	us-gaap	Profit Loss ProfitLoss	391075000	usd
	us-gaap	Profit Loss ProfitLoss	426133000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5379000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5115000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11555000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	12804000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	9866000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5534000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21581000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14478000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	11505000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	13512000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1482000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1744000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	2325000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	6782000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	688389000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-169462000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	223813000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-46618000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	22979000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-31368000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	74372000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-49703000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3012000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-364059000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	607111000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17441000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21045000	usd
	tmhc	Distributions Of Capital From Unconsolidated Entities DistributionsOfCapitalFromUnconsolidatedEntities	5161000	usd
	tmhc	Distributions Of Capital From Unconsolidated Entities DistributionsOfCapitalFromUnconsolidatedEntities	350000	usd
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	45028000	usd
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	24134000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-57308000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-44829000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	2426000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	52093000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	15346000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1608895000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1503098000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1486154000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1559272000	usd
	tmhc	Proceeds From Stock Option Exercises And Issuance Of Restricted Stock Units Net ProceedsFromStockOptionExercisesAndIssuanceOfRestrictedStockUnitsNet	-9431000	usd
	tmhc	Proceeds From Stock Option Exercises And Issuance Of Restricted Stock Units Net ProceedsFromStockOptionExercisesAndIssuanceOfRestrictedStockUnitsNet	13084000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1358000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1310000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	196394000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3568000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	424000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-136959000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-60888000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-558326000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	501394000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	807099000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	726635000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	248773000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1228029000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	125792000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	78877000	usd
	tmhc	Increase Decrease In Loans Payable Issued To Sellers In Connection With Land Purchase Contracts IncreaseDecreaseInLoansPayableIssuedToSellersInConnectionWithLandPurchaseContracts	-149363000	usd
	tmhc	Increase Decrease In Loans Payable Issued To Sellers In Connection With Land Purchase Contracts IncreaseDecreaseInLoansPayableIssuedToSellersInConnectionWithLandPurchaseContracts	-84445000	usd
	tmhc	Noncash Investing And Financing Activities Increase Decrease In Inventory Not Owned NoncashInvestingAndFinancingActivitiesIncreaseDecreaseInInventoryNotOwned	63082000	usd
	tmhc	Noncash Investing And Financing Activities Increase Decrease In Inventory Not Owned NoncashInvestingAndFinancingActivitiesIncreaseDecreaseInInventoryNotOwned	-23079000	usd
	tmhc	Accrual Of Excise Tax Payment On Share Repurchases AccrualOfExciseTaxPaymentOnShareRepurchases	-2125000	usd
	tmhc	Accrual Of Excise Tax Payment On Share Repurchases AccrualOfExciseTaxPaymentOnShareRepurchases	0	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Use of Estimates</span><span style="color:#333333;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> — The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported in the unaudited Condensed consolidated financial statements and accompanying notes. Significant estimates include real estate development costs to complete, valuation of real estate, valuation of goodwill, valuation of estimated development liabilities, valuation of equity awards, valuation allowance on deferred tax assets, and reserves for warranty and self-insured risks. Actual results could differ from those estimates.</span></div>
CY2024Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q2	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2024Q2	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	199460000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	234602000	usd
	us-gaap	Net Income Loss NetIncomeLoss	389730000	usd
	us-gaap	Net Income Loss NetIncomeLoss	425653000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105500000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109210000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105979000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108822000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107249000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110856000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107961000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110466000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.89
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.91
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.86
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.85
CY2024Q2	us-gaap	Inventory Real Estate Held For Sale InventoryRealEstateHeldForSale	4263720000	usd
CY2023Q4	us-gaap	Inventory Real Estate Held For Sale InventoryRealEstateHeldForSale	3855534000	usd
CY2024Q2	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	49307000	usd
CY2023Q4	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	29317000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	4313027000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	3884851000	usd
CY2024Q2	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1666486000	usd
CY2023Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1414528000	usd
CY2024Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	172263000	usd
CY2023Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	174449000	usd
CY2024Q2	tmhc	Inventory Real Estate Owned InventoryRealEstateOwned	6151776000	usd
CY2023Q4	tmhc	Inventory Real Estate Owned InventoryRealEstateOwned	5473828000	usd
CY2024Q2	tmhc	Inventory Real Estate Not Owned InventoryRealEstateNotOwned	134700000	usd
CY2023Q4	tmhc	Inventory Real Estate Not Owned InventoryRealEstateNotOwned	71618000	usd
CY2024Q2	us-gaap	Inventory Real Estate InventoryRealEstate	6286476000	usd
CY2023Q4	us-gaap	Inventory Real Estate InventoryRealEstate	5545446000	usd
CY2024Q2	tmhc	Number Of Lots Owned NumberOfLotsOwned	35000	lot
CY2023Q4	tmhc	Number Of Lots Owned NumberOfLotsOwned	34077	lot
CY2024Q2	tmhc	Number Of Controlled Lots NumberOfControlledLots	45677	lot
CY2023Q4	tmhc	Number Of Controlled Lots NumberOfControlledLots	38285	lot
CY2024Q2	tmhc	Number Of Owned And Controlled Lots NumberOfOwnedAndControlledLots	80677	lot
CY2023Q4	tmhc	Number Of Owned And Controlled Lots NumberOfOwnedAndControlledLots	72362	lot
CY2024Q2	tmhc	Number Of Homes In Inventory NumberOfHomesInInventory	9021	home
CY2023Q4	tmhc	Number Of Homes In Inventory NumberOfHomesInInventory	7867	home
CY2024Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	177222000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	196607000	usd
CY2023Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	174449000	usd
CY2022Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	190123000	usd
CY2024Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	23344000	usd
CY2023Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	32049000	usd
	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	49742000	usd
	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	66182000	usd
CY2024Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	28303000	usd
CY2023Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	37352000	usd
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	51928000	usd
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	65001000	usd
CY2024Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	172263000	usd
CY2023Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	191304000	usd
CY2024Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	172263000	usd
CY2023Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	191304000	usd
CY2024Q2	tmhc	Real Estate Land And Land Development Costs RealEstateLandAndLandDevelopmentCosts	45729000	usd
CY2023Q4	tmhc	Real Estate Land And Land Development Costs RealEstateLandAndLandDevelopmentCosts	46114000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	105915000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	149095000	usd
CY2024Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	181790000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	184448000	usd
CY2024Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	32475000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	31042000	usd
CY2024Q2	tmhc	Accrued Property And Sales Tax AccruedPropertyAndSalesTax	33533000	usd
CY2023Q4	tmhc	Accrued Property And Sales Tax AccruedPropertyAndSalesTax	30887000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	119099000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	107488000	usd
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	518541000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	549074000	usd
CY2024Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	186948000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	158222000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	184448000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	161675000	usd
CY2024Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	21525000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	24887000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	42190000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	39334000	usd
CY2024Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	28713000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	23318000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	49906000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	43826000	usd
CY2024Q2	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	2030000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	535000	usd
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	5058000	usd
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	3143000	usd
CY2024Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	181790000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	160326000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2157517000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	7496000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	2150021000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2025477000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	8375000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2017102000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2024Q2	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	276205000	usd
CY2024Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	360000000	usd
CY2023Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	153464000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	360000000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.252
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.242
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.256
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.245
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2024Q2	tmhc	Number Of Agreements NumberOfAgreements	2	agreement
CY2024Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1703803	shares
CY2023Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	3195288	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	109325	shares
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	402840000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	275570000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	494489000	usd
CY2022Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	279138000	usd
CY2024Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	104745000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	0	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	196394000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3568000	usd
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	298095000	usd
CY2023Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	275570000	usd
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	298095000	usd
CY2023Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	275570000	usd
CY2022Q3	tmhc	Percentage Of Excise Tax On Net Repurchase Of Stock PercentageOfExciseTaxOnNetRepurchaseOfStock	0.01
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6072000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5271000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11555000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12804000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	40700000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	26500000	usd
	tmhc	Number Of Reportable Segments Included In Operating Component NumberOfReportableSegmentsIncludedInOperatingComponent	3	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1991053000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	472288000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	196735000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2628000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10964000	usd
CY2024Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	267217000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2060564000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	499685000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	183683000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3186000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3429000	usd
CY2023Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	315759000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3690805000	usd
	us-gaap	Gross Profit GrossProfit	889133000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	366899000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5379000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11516000	usd
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	516097000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3722421000	usd
	us-gaap	Gross Profit GrossProfit	899251000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	342704000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5115000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2516000	usd
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	564178000	usd
CY2024Q2	tmhc	Real Estate Inventory And Land Deposits RealEstateInventoryAndLandDeposits	6491027000	usd
CY2024Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	381571000	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	2226471000	usd
CY2024Q2	us-gaap	Assets Assets	9099069000	usd
CY2023Q4	tmhc	Real Estate Inventory And Land Deposits RealEstateInventoryAndLandDeposits	5748663000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	346192000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	2577232000	usd
CY2023Q4	us-gaap	Assets Assets	8672087000	usd
CY2024Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1400000000	usd
CY2023Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1300000000	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	35300000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	26200000	usd
CY2023Q4	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	64700000	usd
CY2024Q2	tmhc	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	82100000	usd
CY2023Q4	tmhc	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	85000000.0	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	5600000	usd
	us-gaap	Lease Cost LeaseCost	11500000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	6400000	usd
	us-gaap	Lease Cost LeaseCost	13500000	usd
CY2024Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1004000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3566000	usd
CY2024Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	306900000	usd
CY2023Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	242600000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-032842-index-headers.html	Edgar Link	pending
0001628280-24-032842-index.html	Edgar Link	pending
0001628280-24-032842.txt	Edgar Link	pending
0001628280-24-032842-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmhc-20240630.htm	Edgar Link	pending
tmhc-20240630.xsd	Edgar Link	pending
tmhc-20240630xexx311.htm	Edgar Link	pending
tmhc-20240630xexx312.htm	Edgar Link	pending
tmhc-20240630xexx321.htm	Edgar Link	pending
tmhc-20240630xexx322.htm	Edgar Link	pending
tmhc-20240630_cal.xml	Edgar Link	unprocessable
tmhc-20240630_def.xml	Edgar Link	unprocessable
tmhc-20240630_lab.xml	Edgar Link	unprocessable
tmhc-20240630_pre.xml	Edgar Link	unprocessable
tmhc-20240630_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TMHC
Taylor Morrison Home Corp Stock $tmhc

2024 Q3 Form 10-Q Financial Statement

#000162828024032842 Filed on July 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMHC Taylor Morrison Home Corp Stock $tmhc

2024 Q3 Form 10-Q Financial Statement

#000162828024032842 Filed on July 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMHC
Taylor Morrison Home Corp Stock $tmhc